We are live on ! Find out more
IRC

Investors Research Corp Portfolio holdings

AUM $559M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
+25.43%
1 Year Est. Return
+21.55%
3 Year Est. Return
+57.22%
5 Year Est. Return
+62.75%
10 Year Est. Return
AUM
$254M
AUM Growth
+$48.1M
Cap. Flow
+$2.54M
Cap. Flow %
1%
Top 10 Hldgs %
9.84%
Holding
1,138
New
19
Increased
104
Reduced
237
Closed
44

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.3%
2 Technology 10.47%
3 Industrials 10.41%
4 Financials 10.3%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
1101
NextEra Energy
NEE
$179B
-16
Closed -$1K
OTIS icon
1102
Otis Worldwide
OTIS
$27.8B
$0 ﹤0.01%
3
PSCH icon
1103
Invesco S&P SmallCap Health Care ETF
PSCH
$172M
-186,039
Closed -$972K
ECHO
1104
EchoStar
ECHO
$25.6B
$0 ﹤0.01%
17
SPB icon
1105
Spectrum Brands
SPB
$2.02B
-1,111
Closed -$64K
TMO icon
1106
Thermo Fisher Scientific
TMO
$224B
-60
Closed -$26K
UTHR icon
1107
United Therapeutics
UTHR
$22.1B
-200
Closed -$20K
UTSI icon
1108
UTStarcom
UTSI
$23.2M
-358
Closed -$2K
VNT icon
1109
Vontier
VNT
$4.61B
$0 ﹤0.01%
+14
New +$432
YARW
1110
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
0
ZTS icon
1111
Zoetis
ZTS
$31.1B
-33
Closed -$5K
ZUO
1112
DELISTED
Zuora, Inc.
ZUO
$0 ﹤0.01%
+25
New +$284
TDW.WS
1113
DELISTED
Tidewater Inc.
TDW.WS
$0 ﹤0.01%
632
SBOW
1114
DELISTED
SilverBow Resources, Inc.
SBOW
$0 ﹤0.01%
23
CHS
1115
DELISTED
Chicos FAS, Inc.
CHS
-2,000
Closed -$2K
TDW.WS.A
1116
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$0 ﹤0.01%
935
-12
-1% -$7
TDW.WS.B
1117
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$0 ﹤0.01%
1,010
-13
-1% -$4
TCRR
1118
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-69
Closed -$1K
SEAC
1119
DELISTED
Seachange International Inc
SEAC
-40
Closed -$1K
SIOX
1120
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$0 ﹤0.01%
100
SRNE
1121
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$0 ﹤0.01%
50
LORL
1122
DELISTED
Loral Space and Communications, Inc.
LORL
$0 ﹤0.01%
21
MXIM
1123
DELISTED
Maxim Integrated Products
MXIM
-2,680
Closed -$181K
GEN
1124
DELISTED
Genesis Healthcare, Inc.
GEN
-2,000
Closed -$1K
PRVL
1125
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-62
Closed -$1K

Similar funds

Investors Research Corp's Q4 2020 Portfolio in Review

As of Q4 2020, Investors Research Corp held 1,138 positions worth $254M, up 23% from $206M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Investors Research Corp's Q4 2020 filing shows 19 new, 104 increased, 237 reduced and 44 closed positions. Its largest new stake was Invesco S&P SmallCap High Dividend Low Volatility ETF: 51,405 shares worth $1.03M. The largest sale was Direxion All Cap Insider Sentiment Shares, an estimated $1.16M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.

  • Investors Research Corp's largest Q4 2020 buy was Invesco S&P SmallCap High Dividend Low Volatility ETF: 51,405 shares worth $1.03M.
  • Investors Research Corp added most to State Street Energy Select Sector SPDR ETF in Q4 2020, an estimated $557K increase.
  • Investors Research Corp's biggest Q4 2020 reduction was Penske Automotive Group, cutting an estimated $287K.
  • Investors Research Corp fully exited Direxion All Cap Insider Sentiment Shares in Q4 2020, selling an estimated $1.16M.
  • Investors Research Corp's ten largest holdings make up 9.8% of its $254M portfolio in Q4 2020.
  • Investors Research Corp opened 19 new positions and closed 44 in Q4 2020.
  • Investors Research Corp's portfolio value rose 23% quarter-over-quarter to $254M.

Based on Investors Research Corp's 13F filing for Q4 2020, filed 21 Jan 2021.